NEUPHORIA THERAPEUTICS Trademark
Trademark Overview
On Monday, July 1, 2024, a trademark application was filed for NEUPHORIA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the NEUPHORIA THERAPEUTICS trademark a serial number of 98627366. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 27, 2025. This trademark is owned by Neuphoria Therapeutics Inc.. The NEUPHORIA THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceuticals, namely biopharmaceutical products for treatment of central nervous system disorders
Biological research services, namely research services related to Biopharmaceutical products for treatment of central nervous system disorders
General Information
Serial Number | 98627366 |
Word Mark | NEUPHORIA THERAPEUTICS |
Filing Date | Monday, July 1, 2024 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, May 27, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, May 27, 2025 |
Trademark Statements
Goods and Services | Pharmaceuticals, namely biopharmaceutical products for treatment of central nervous system disorders |
NOT AVAILABLE | THERAPEUTICS |
Goods and Services | Biological research services, namely research services related to Biopharmaceutical products for treatment of central nervous system disorders |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, July 1, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, July 1, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Neuphoria Therapeutics Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Dover, DE 19904 |
Party Name | Neuphoria Therapeutics Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Dover, DE 19904 |
Trademark Events
Event Date | Event Description |
Monday, July 1, 2024 | NEW APPLICATION ENTERED |
Tuesday, January 14, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, January 27, 2025 | NON-FINAL ACTION WRITTEN |
Monday, January 27, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, January 27, 2025 | NON-FINAL ACTION E-MAILED |
Friday, April 25, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, April 25, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, April 25, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, April 28, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, January 21, 2025 | ASSIGNED TO EXAMINER |
Tuesday, May 27, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Wednesday, May 21, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, May 27, 2025 | PUBLISHED FOR OPPOSITION |
Thursday, June 5, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Thursday, June 5, 2025 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Thursday, June 5, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, June 5, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |